Minim Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
David Lazar
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.9% |
Management average tenure | no data |
Board average tenure | less than a year |
Recent management updates
Recent updates
Minim, Inc.'s (NASDAQ:MINM) Shares Bounce 35% But Its Business Still Trails The Industry
Feb 15Pontera appoints Nicole Zheng as CMO
Sep 21Minim names finance chief Mehul Patel as CEO
Aug 16Minim announces plan for President & CMO transition
Jul 08Is Minim (NASDAQ:MINM) Using Debt Sensibly?
Feb 11Is Minim, Inc. (NASDAQ:MINM) Worth US$1.5 Based On Its Intrinsic Value?
Nov 10CEO
David Lazar (33 yo)
less than a year
Tenure
Mr. David Elliot Lazar had been Chief Business Development Officer of TRACON Pharmaceuticals, Inc. from May 7, 2024 until June 19, 2024. He was Chairman and CEO of OpGen, Inc. from March 25, 2024 Until Aug...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | less than a year | no data | 0.89% $ 80.0k | |
Independent Director | less than a year | US$10.33k | 0.89% $ 80.0k | |
Independent Director | less than a year | no data | 0.89% $ 80.0k | |
Independent Director | less than a year | no data | 0.89% $ 80.0k | |
Independent Director of the Board | 1.7yrs | US$57.63k | 0.99% $ 89.2k | |
Independent Director | 1.1yrs | US$47.83k | 0.96% $ 86.4k |
0.7yrs
Average Tenure
52yo
Average Age
Experienced Board: MINM's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.